∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.LONDON, Dec. 2, 2025 /PRNewswire/…
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes…
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight…
Wednesday 2 July, 2025 A Sussex man is preparing to paddleboard across the English Channel to raise funds for children’s…